Cargando…
Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
Diabetes is a common chronic disease affecting millions of people worldwide. It underlies various complications and imposes many costs on individuals and society. Discovering early diagnostic biomarkers takes excellent insight into preventive plans and the best use of interventions. Therefore, in th...
Autores principales: | Hosseinkhani, Shaghayegh, Arjmand, Babak, Dilmaghani-Marand, Arezou, Mohammadi Fateh, Sahar, Dehghanbanadaki, Hojat, Najjar, Niloufar, Alavi-Moghadam, Sepideh, Ghodssi-Ghassemabadi, Robabeh, Nasli-Esfahani, Ensieh, Farzadfar, Farshad, Larijani, Bagher, Razi, Farideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119932/ https://www.ncbi.nlm.nih.gov/pubmed/35589736 http://dx.doi.org/10.1038/s41598-022-11970-7 |
Ejemplares similares
-
The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016
por: Taghizadeh, Hananeh, et al.
Publicado: (2023) -
Association of plasma acylcarnitines and amino acids with hypertension: A nationwide metabolomics study
por: Arjmand, Babak, et al.
Publicado: (2023) -
Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC–MS/MS based metabolomics approach
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022) -
Metabolic signatures of insulin resistance in non-diabetic individuals
por: Arjmand, Babak, et al.
Publicado: (2022) -
Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)